Micro Emerging Active

JNJ ICOTYDE Shows Promise In Plaque Psoriasis Treatment

New narrative with limited coverage — still forming.

Score
0.3
Velocity
▲ 0.0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

Mar 28, 2026
Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis Neutral

Related Articles

Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis

Nasdaq · Mar 28, 2026
Mixed

Timeline

First SeenMar 28, 2026
Last UpdatedMar 28, 2026